Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.819
Filter
1.
Stress ; 27(1): 2353781, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38823417

ABSTRACT

Hypothalamic-pituitary-adrenal (HPA)-axis hyperactivity measured by the combined dexamethasone-CRH test (DEX-CRH test) has been found in patients with major depressive disorder (MDD), whereas hypoactivity has been found in patients with work-related stress. We aimed to investigate the DEX-CRH test as a biomarker to distinguish between MDD and work-related stress (exhaustion disorder - ED). We hypothesized that there would be lower cortisol and ACTH response in participants with ED compared to MDD and healthy controls (HC). Also, we explored if the cortisol response of those patients interacted with robust markers of oxidative stress. Thirty inpatients with MDD and 23 outpatients with ED were recruited. Plasma cortisol and ACTH were sampled during a DEX-CRH test. The main outcome measure, area under the curve (AUC) for cortisol and ACTH, was compa-red between MDD vs. ED participants and a historical HC group. Secondary markers of oxidative stress urinary 8-oxodG and 8-oxoGuo; quality of sleep and psychometrics were obtained. Cortisol concentrations were higher in MDD and ED participants compared to HC, and no differences in AUC cortisol and ACTH were found between ED vs. MDD. Compared to ED, MDD participants had higher stress symptom severity and a lower sense of well-being. No differences in oxidative stress markers or quality of sleep between the groups were found. The result indicates that the patients with ED, like patients with MDD, are non-suppressors in DEX-CRH test and not hypocortisolemic as suggested.


Subject(s)
Adrenocorticotropic Hormone , Biomarkers , Depressive Disorder, Major , Dexamethasone , Hydrocortisone , Oxidative Stress , Humans , Depressive Disorder, Major/blood , Depressive Disorder, Major/physiopathology , Depressive Disorder, Major/diagnosis , Female , Male , Hydrocortisone/blood , Adult , Oxidative Stress/physiology , Adrenocorticotropic Hormone/blood , Biomarkers/blood , Dexamethasone/pharmacology , Middle Aged , Corticotropin-Releasing Hormone/blood , Occupational Stress/physiopathology , Hypothalamo-Hypophyseal System/physiopathology , Hypothalamo-Hypophyseal System/metabolism , Pituitary-Adrenal System/physiopathology
2.
Dev Psychobiol ; 66(5): e22494, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38698641

ABSTRACT

Though considerable work supports the Dimensional Model of Adversity and Psychopathology, prior research has not tested whether the dimensions-threat (e.g., abuse) and deprivation (e.g., neglect)-are uniquely related to salivary trait indicators of hypothalamic pituitary adrenal (HPA) axis activity. We examined the unique and interactive effects of threat and deprivation on latent trait cortisol (LTC)-and whether these effects were modified by co-occurring adversities. Emerging adults (n = 90; Mage = 19.36 years; 99.88% cisgender women) provided salivary cortisol samples four times a day (waking, 30 min and 45 min postwaking, bedtime) over three 3-day measurement waves over 13 weeks. Contextual life stress interviews assessed early adversity. Though the effects varied according to the conceptualization of early adversity, overall, threat-but not deprivation, nor other co-occurring adversities-was uniquely associated with the across-wave LTC. Specifically, the incidence and frequency of threat were each negatively related to the across-wave LTC. Threat severity was also associated with the across-wave LTC, but only among those with no deprivation. Finally, the effects of threat were modified by other co-occurring adversities. Findings suggest that threat has unique implications for individual differences in HPA axis activity among emerging adults, and that co-occurring adversities modify such effects.


Subject(s)
Hydrocortisone , Hypothalamo-Hypophyseal System , Saliva , Humans , Female , Male , Hydrocortisone/metabolism , Young Adult , Adult , Saliva/metabolism , Saliva/chemistry , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Adolescent , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Adverse Childhood Experiences , Psychosocial Deprivation
3.
Ann Med ; 56(1): 2356667, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38776237

ABSTRACT

BACKGROUND: The lack of association between serum testosterone levels and symptoms suggestive of hypogonadism is a significant barrier in the determination of late-onset hypogonadism (LOH) in men. This study explored whether testosterone levels increase after morning awakening, likewise the cortisol awakening response (CAR) in the hypothalamic-pituitary-adrenal (HPA) axis, and whether testosterone levels during the post-awakening period are associated with age and symptoms suggestive of late-onset hypogonadism (LOH) in men. METHODS: Testosterone and cortisol levels were determined in saliva samples collected immediately upon awakening and 30 and 60 min after awakening, and scores of the Aging Males' Symptoms (AMS) questionnaire were obtained from 225 healthy adult men. RESULTS: A typical CAR (an increase in cortisol level ≥ 2.5 nmol/L above individual baseline) was observed in 155 participants (the subgroup exhibiting typical CAR). In the subgroup exhibiting CAR, testosterone levels sharply increased during the post-awakening period, showing a significant negative correlation with age, total AMS score, and the scores of 11 items on the somatic, psychological, and sexual AMS subscales. Of these items, three sexual items (AMS items #15-17) were correlated with age. Meanwhile, there was no notable increase in testosterone levels and no significant correlation of testosterone levels with age and AMS score in the subgroup exhibiting no typical CAR (n = 70). CONCLUSIONS: The results indicate that the hypothalamus-pituitary-gonad (HPG) axis responds to morning awakening, and determining testosterone levels during the post-awakening period in men with typical CAR may be useful for assessing HPG axis function and LOH.


The present study found that the HPG axis in healthy adult men responds to the morning awakening, characterized by increased salivary testosterone levels after the awakening period.The levels of salivary testosterone during the first hour after awakening are negatively associated with age and the severity of symptoms suggestive of LOH in adult men with typical CAR.


Subject(s)
Hydrocortisone , Hypogonadism , Hypothalamo-Hypophyseal System , Saliva , Testosterone , Humans , Male , Testosterone/analysis , Testosterone/blood , Testosterone/metabolism , Saliva/chemistry , Saliva/metabolism , Hypogonadism/metabolism , Hypogonadism/blood , Hypogonadism/diagnosis , Middle Aged , Adult , Hydrocortisone/metabolism , Hydrocortisone/blood , Hydrocortisone/analysis , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Aged , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Aging/metabolism , Aging/physiology , Surveys and Questionnaires , Age Factors , Young Adult , Wakefulness/physiology
4.
Dev Psychobiol ; 66(5): e22490, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38680082

ABSTRACT

Psychological stress is a ubiquitous facet of modern life, impacting individuals across diverse contexts and demographics. Understanding its physiological manifestations through biomarkers has gained substantial attention within the scientific community. A comprehensive search was conducted across multiple databases for peer-reviewed articles published within the past decade. Preliminary findings reveal many biomarkers associated with psychological stress across different biological systems, including the hypothalamic-pituitary-adrenal axis, immune system, cardiovascular system, and central nervous system. This systematic review explores psychological, physiological, and biochemical biomarkers associated with stress. Analyzing recent literature, it synthesizes findings across these three categories, elucidating their respective roles in stress response mechanisms. Psychological markers involve subjective assessments like self-reported stress levels, perceived stress scales, or psychometric evaluations measuring anxiety, depression, or coping mechanisms. Physiological markers include heart rate variability, blood pressure, and immune system responses such as cytokine levels or inflammatory markers. Biochemical markers involve hormones or chemicals linked to stress. It includes cortisol, catecholamines, copeptin, salivary amylase, IL-6, and C-reactive protein.


Subject(s)
Biomarkers , Stress, Psychological , Humans , Biomarkers/analysis , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Stress, Psychological/metabolism , Stress, Psychological/physiopathology
5.
Psychoneuroendocrinology ; 165: 107039, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38581748

ABSTRACT

OBJECTIVE: Childhood trauma may contribute to poor lifelong health in part through programming of the HPA-axis response to future life stressors. To date, empirical evidence shows an association of childhood trauma with dysregulation of the HPA-axis and blunted cortisol reactivity to acute stressors. Here, we conduct an initial examination of childhood trauma as a moderator of changes over time in perceived stress levels and HPA-axis response to a major chronic stressor in adulthood. METHODS: Participants were 83 maternal caregivers of children newly diagnosed with cancer who completed the Childhood Trauma Questionnaire (CTQ), and who, over the year following their child's cancer diagnosis, had hair samples collected up to 7 times for the assessment of cortisol and completed monthly measures of perceived stress. RESULTS: CTQ scores were in the expected range for a community sample and associated with changes in perceived stress and cortisol concentration over time (γ =.003, p =.002; γ = -.0004, p =.008, respectively) independently of age, education, treatment intensity and randomization to stress management intervention. Maternal caregivers who endorsed lower childhood trauma showed a steeper decline in perceived stress and a larger increase in cortisol levels across the year than caregivers who recalled more childhood trauma. CONCLUSIONS: Findings extend animal models and studies that examine cortisol reactivity to acute stressors and suggest that childhood trauma may program a phenotype that is more psychologically reactive but shows a blunted HPA-axis response to chronic stress. While adaptive in the short-term, this early life programming may incur long-term costs for health. Further work is warranted to examine this possibility.


Subject(s)
Adverse Childhood Experiences , Hair , Hydrocortisone , Hypothalamo-Hypophyseal System , Pituitary-Adrenal System , Stress, Psychological , Humans , Hair/chemistry , Hair/metabolism , Hydrocortisone/metabolism , Hydrocortisone/analysis , Female , Stress, Psychological/metabolism , Adult , Hypothalamo-Hypophyseal System/metabolism , Male , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Life Change Events , Middle Aged , Child , Surveys and Questionnaires , Caregivers/psychology , Mothers/psychology
6.
Psychoneuroendocrinology ; 165: 107037, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38613946

ABSTRACT

The present pilot study assessed the effects of multi-session intermittent theta-burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex in 17 treatment resistant depressed inpatients (TRDs) showing cortisol non-suppression to the overnight dexamethasone suppression test (DST) at baseline (i.e., maximum post-DST cortisol [CORmax] level > 130 nmol/L). After 20 iTBS sessions, the DST was repeated in all TRDs. At baseline, post-DST CORmax levels were higher in TRDs compared to healthy control subjects (HCs; n = 17) (p < 0.0001). After 20 iTBS sessions, post-DST CORmax levels decreased from baseline (p < 0.03) and were comparable to HCs. Decreases in post-DST CORmax levels were related to decreases in 17-item Hamilton Depression Rating Scale (HAMD-17) scores (ρ = 0.53; p < 0.03). At endpoint, 10 TRDs showed DST normalization (among them 7 were responders [i.e., HAMD-17 total score > 50% decrease from baseline]), and 7 did not normalize their DST (among them 6 were non-responders) (p < 0.05). Our results suggest that successful iTBS treatment may restore normal glucocorticoid receptor feedback inhibition at the pituitary level.


Subject(s)
Depressive Disorder, Treatment-Resistant , Dexamethasone , Hydrocortisone , Hypothalamo-Hypophyseal System , Pituitary-Adrenal System , Transcranial Magnetic Stimulation , Humans , Male , Female , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Adult , Hydrocortisone/metabolism , Hydrocortisone/analysis , Transcranial Magnetic Stimulation/methods , Middle Aged , Depressive Disorder, Treatment-Resistant/therapy , Depressive Disorder, Treatment-Resistant/physiopathology , Depressive Disorder, Treatment-Resistant/metabolism , Pilot Projects , Dorsolateral Prefrontal Cortex/metabolism , Dorsolateral Prefrontal Cortex/physiology , Theta Rhythm/physiology , Treatment Outcome
7.
Psychoneuroendocrinology ; 165: 107049, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38657340

ABSTRACT

BACKGROUND: Past studies on schizophrenia (SCZ) and the stress-sensitive neuroendocrine systems have mostly focused on a single system and traditionally utilized acute biomarkers (e.g., biomarkers from blood, urine and saliva) that poorly match the chronic course of schizophrenia in time span. Using eight biomarkers in hair, this study aimed to explore the functional characteristics of SCZ patients in the hypothalamic-pituitary-adrenocortical (HPA) and hypothalamic-pituitary-gonadal (HPG) axes and the interaction between the two axes. METHODS: Hair samples were taken from 137 SCZ patients and 73 controls. The SCZ patients were diagnosed by their attending physician according to the Diagnostic and Statistical Manual of Mental Disorders IV and were clinically stable after treatment. Gender, age, BMI, frequency of hair washing, marital status, education level, family history of mental illness and clozapine dosage were concurrently collected as covariates. The 10-item perceived stress scale (PSS-10) and the social readjustment rating scale were used to assess chronic stress status in SCZ patients. Eight hair biomarkers, cortisol, cortisone, dehydroepiandrosterone (DHEA), testosterone, progesterone, cortisol/cortisone, cortisol/DHEA and cortisol/testosterone, were measured by high performance liquid chromatography tandem mass spectrometer. Among them, cortisol, cortisone, DHEA and cortisol/DHEA reflected the functional activity of the HPA axis, and testosterone and progesterone reflected the functional activity of the HPG axis, and cortisol/cortisone reflected the activity of 11ß-hydroxysteroid dehydrogenase types 2 (11ß-HSD 2), and cortisol/testosterone reflected the HPA-HPG interaction. RESULTS: SCZ patients showed significantly higher cortisone and cortisol/testosterone than controls (p<0.001, η²p=0.180 and p=0.015, η²p=0.031), lower testosterone (p=0.009, η²p=0.034), progesterone (p<0.001, η²p=0.069) and cortisol/cortisone (p=0.001, η²p=0.054). There were significant intergroup differences in male and female progesterone (p=0.003, η²p=0.088 and p=0.030, η²p=0.049) and female testosterone (p=0.028, η²p=0.051). In SCZ patients, cortisol, cortisol/cortisone, cortisol/DHEA and cortisol/testosterone were positively associated with PSS-10 score (ps<0.05, 0.212

Subject(s)
Biomarkers , Cortisone , Dehydroepiandrosterone , Hair , Hydrocortisone , Hypothalamo-Hypophyseal System , Pituitary-Adrenal System , Schizophrenia , Stress, Psychological , Testosterone , Humans , Female , Male , Hypothalamo-Hypophyseal System/metabolism , Schizophrenia/metabolism , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Hair/chemistry , Hair/metabolism , Biomarkers/metabolism , Adult , Hydrocortisone/metabolism , Hydrocortisone/analysis , Cortisone/metabolism , Cortisone/analysis , Testosterone/metabolism , Testosterone/analysis , Dehydroepiandrosterone/metabolism , Dehydroepiandrosterone/analysis , Stress, Psychological/metabolism , Middle Aged , Progesterone/metabolism , Progesterone/analysis , Case-Control Studies
8.
Sleep Med Rev ; 75: 101929, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38581800

ABSTRACT

Obstructive sleep apnea (OSA) is associated with ischemic stroke. There is, however, a lack of knowledge on the exact cause-effect relationship, and preclinical models of OSA for experimental ischemic stroke investigations are not well characterized. In this review, we discuss sleep apnea and its relationship with stroke risk factors. We consider how OSA may lead to ischemic stroke and how OSA-induced metabolic syndrome and hypothalamic-pituitary axis (HPA) dysfunction could serve as therapeutic targets to prevent ischemic stroke. Further, we examine the translational potential of established preclinical models of OSA. We conclude that metabolic syndrome and HPA dysfunction, which are often overlooked in the context of experimental stroke and OSA studies, are crucial for experimental consideration to improve the body of knowledge as well as the translational potential of investigative efforts.


Subject(s)
Hypothalamo-Hypophyseal System , Ischemic Stroke , Sleep Apnea, Obstructive , Humans , Ischemic Stroke/physiopathology , Ischemic Stroke/complications , Animals , Sleep Apnea, Obstructive/complications , Sleep Apnea, Obstructive/physiopathology , Hypothalamo-Hypophyseal System/physiopathology , Disease Models, Animal , Risk Factors , Translational Research, Biomedical , Metabolic Syndrome/physiopathology , Metabolic Syndrome/complications , Pituitary-Adrenal System/physiopathology , Sleep Apnea Syndromes/complications , Sleep Apnea Syndromes/physiopathology
9.
Neurobiol Dis ; 195: 106499, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38588753

ABSTRACT

The gut-brain axis is a bidirectional communication network linking the gut and the brain, overseeing digestive functions, emotional responses, body immunity, brain development, and overall health. Substantial research highlights a connection between disruptions of the gut-brain axis and various psychiatric and neurological conditions, including depression and Alzheimer's disease. Given the impact of the gut-brain axis on behavior, cognition, and brain diseases, some studies have started to pay attention to the role of the axis in sepsis-associated encephalopathy (SAE), where cognitive impairment is the primary manifestation. SAE emerges as the primary and earliest form of organ dysfunction following sepsis, potentially leading to acute cognitive impairment and long-term cognitive decline in patients. Notably, the neuronal damage in SAE does not stem directly from the central nervous system (CNS) infection but rather from an infection occurring outside the brain. The gut-brain axis is posited as a pivotal factor in this process. This review will delve into the gut-brain axis, exploring four crucial pathways through which inflammatory signals are transmitted and elevate the incidence of SAE. These pathways encompass the vagus nerve pathway, the neuroendocrine pathway involving the hypothalamic-pituitary-adrenal (HPA) axis and serotonin (5-HT) regulation, the neuroimmune pathway, and the microbial regulation. These pathways can operate independently or collaboratively on the CNS to modulate brain activity. Understanding how the gut affects and regulates the CNS could offer the potential to identify novel targets for preventing and treating this condition, ultimately enhancing the prognosis for individuals with SAE.


Subject(s)
Brain-Gut Axis , Brain , Sepsis-Associated Encephalopathy , Humans , Brain-Gut Axis/physiology , Sepsis-Associated Encephalopathy/physiopathology , Sepsis-Associated Encephalopathy/metabolism , Animals , Brain/physiopathology , Brain/metabolism , Gastrointestinal Microbiome/physiology , Hypothalamo-Hypophyseal System/physiopathology , Hypothalamo-Hypophyseal System/metabolism , Pituitary-Adrenal System/physiopathology , Pituitary-Adrenal System/metabolism , Sepsis/physiopathology , Sepsis/complications
10.
Neuroimmunomodulation ; 31(1): 78-88, 2024.
Article in English | MEDLINE | ID: mdl-38527434

ABSTRACT

BACKGROUND: The brain and the immune systems represent the two primary adaptive systems within the body. Both are involved in a dynamic process of communication, vital for the preservation of mammalian homeostasis. This interplay involves two major pathways: the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. SUMMARY: The establishment of infection can affect immunoneuroendocrine interactions, with functional consequences for immune organs, particularly the thymus. Interestingly, the physiology of this primary organ is not only under the control of the central nervous system (CNS) but also exhibits autocrine/paracrine regulatory circuitries mediated by hormones and neuropeptides that can be altered in situations of infectious stress or chronic inflammation. In particular, Chagas disease, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), impacts upon immunoneuroendocrine circuits disrupting thymus physiology. Here, we discuss the most relevant findings reported in relation to brain-thymic connections during T. cruzi infection, as well as their possible implications for the immunopathology of human Chagas disease. KEY MESSAGES: During T. cruzi infection, the CNS influences thymus physiology through an intricate network involving hormones, neuropeptides, and pro-inflammatory cytokines. Despite some uncertainties in the mechanisms and the fact that the link between these abnormalities and chronic Chagasic cardiomyopathy is still unknown, it is evident that the precise control exerted by the brain over the thymus is markedly disrupted throughout the course of T. cruzi infection.


Subject(s)
Brain , Chagas Disease , Thymus Gland , Humans , Chagas Disease/immunology , Chagas Disease/physiopathology , Animals , Brain/immunology , Thymus Gland/immunology , Thymus Gland/physiology , Trypanosoma cruzi/physiology , Trypanosoma cruzi/immunology , Hypothalamo-Hypophyseal System/immunology , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Neuroimmunomodulation/physiology , Neuroimmunomodulation/immunology , Pituitary-Adrenal System/immunology , Pituitary-Adrenal System/physiopathology , Pituitary-Adrenal System/metabolism
11.
Psychoneuroendocrinology ; 165: 107034, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38554595

ABSTRACT

BACKGROUND: Despite evidence that early life stress (ELS) can influence the functioning of the hypothalamic-pituitary-adrenal (HPA) axis and increase maladaptive behaviors in adolescence, less attention has been paid to the role of the coordinated effects of the two primary adrenal hormones, cortisol and dehydroepiandrosterone (DHEA), in these associations. METHODS: 138 typically developing adolescents (76 females) reported the stressful events experienced during childhood and early adolescence across 30 domains. Two years later we assessed levels of externalizing problems and obtained salivary levels of cortisol and DHEA. Using causal moderated mediation analyses, we examined whether the ratio of cortisol to DHEA (CD ratio) mediates the association between ELS and subsequent externalizing problems. RESULTS: We found that ELS is associated with both a lower CD ratio and more externalizing problems. Importantly, a lower CD ratio mediated the association between ELS and externalizing problems in boys. CONCLUSIONS: An imbalance in adrenal hormones may be a mechanism through which ELS leads to an increase in externalizing problems in adolescent boys. These findings underscore the utility of using the CD ratio to index HPA-axis functioning.


Subject(s)
Adverse Childhood Experiences , Dehydroepiandrosterone , Hydrocortisone , Hypothalamo-Hypophyseal System , Pituitary-Adrenal System , Saliva , Stress, Psychological , Humans , Male , Hydrocortisone/metabolism , Hydrocortisone/analysis , Adolescent , Dehydroepiandrosterone/metabolism , Dehydroepiandrosterone/analysis , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Saliva/chemistry , Saliva/metabolism , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Female , Child , Adolescent Behavior/physiology , Adolescent Behavior/psychology , Problem Behavior/psychology
12.
J Eur Acad Dermatol Venereol ; 38(5): 821-834, 2024 May.
Article in English | MEDLINE | ID: mdl-38311707

ABSTRACT

Inflammatory skin diseases are known to negatively impact patient psychology, with individuals experiencing higher rates of stress and subsequent diminished quality of life, as well as mental health issues including anxiety and depression. Moreover, increased psychological stress has been found to exacerbate existing inflammatory skin diseases. The association between inflammatory skin diseases and psychological stress is a timely topic, and a framework to better understand the relationship between the two that integrates available literature is needed. In this narrative review article, we discuss potential neurobiological mechanisms behind psychological stress due to inflammatory skin diseases, focusing mainly on proinflammatory cytokines in the circulating system (the brain-gut-skin communications) and the default mode network in the brain. We also discuss potential descending pathways from the brain that lead to aggravation of inflammatory skin diseases due to psychological stress, including the central and peripheral hypothalamic-pituitary-adrenal axes, peripheral nerves and the skin barrier function.


Subject(s)
Stress, Psychological , Humans , Stress, Psychological/physiopathology , Hypothalamo-Hypophyseal System/physiopathology , Cytokines/metabolism , Brain/physiopathology , Dermatitis/psychology , Dermatitis/physiopathology , Pituitary-Adrenal System/physiopathology , Skin Diseases/physiopathology , Skin Diseases/psychology , Skin
13.
J Osteopath Med ; 124(6): 267-275, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38414339

ABSTRACT

CONTEXT: Osteopathic treatments regulate the neurovegetative system through joint mobilizations and manipulations, and myofascial and craniosacral techniques. Despite the growing body of research, the precise impact of osteopathic medicine on the autonomic nervous system (ANS) is not yet fully elucidated. As to Kuchera's techniques, the stimulation of the sympathetic trunk and prevertebral ganglia contributed to harmonization of the sympathetic activity. However, potential relationships between the harmonization of the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis largely remain uncertain and warrant further exploration. OBJECTIVES: This study was designed to evaluate the effectiveness of the osteopathic sympathetic harmonization (OSH) on the SNS and the HPA axis in youth with major depressive disorder (MDD). METHODS: The study included 39 youths aged 15-21 years and diagnosed with MDD. The participants were randomly assigned into either the OSH or the placebo group. Stimulation was performed on the sympathetic truncus and prevertebral ganglia in the OSH group. The stimulation of the placebo group was performed with a lighter touch and a shorter duration in similar areas. Each participant completed the Beck Depression Inventory (BDI) and the State and Trait Anxiety Inventory (SAI and TAI) before the application. Blood pressure (BP) and pulse measurements were made, and saliva samples were taken before, immediately after, and 20 min after application. RESULTS: The baseline BDI (p=0.617) and TAI (p=0.322) scores were similar in both groups. Although the SAI scores decreased in both groups postintervention, no statistically significant difference was found between the two groups. Subjects who received OSH had a decrease in α-amylase level (p=0.028) and an increase in cortisol level (p=0.009) 20 min after the procedure. CONCLUSIONS: Following OSH application in depressed youth, SNS activity may decrease, whereas HPA axis activity may increase. Future studies may examine the therapeutic efficacy of repeated OSH applications in depressed individuals.


Subject(s)
Depressive Disorder, Major , Hypothalamo-Hypophyseal System , Manipulation, Osteopathic , Pituitary-Adrenal System , Humans , Depressive Disorder, Major/therapy , Depressive Disorder, Major/physiopathology , Adolescent , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Male , Female , Double-Blind Method , Young Adult , Manipulation, Osteopathic/methods , Hydrocortisone/metabolism , Sympathetic Nervous System/physiopathology , Treatment Outcome
14.
J Pain ; 25(6): 104464, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38246254

ABSTRACT

Chronic low back pain (cLBP) is one of the leading causes of disability globally and represents an enormous burden to aging adults. While numerous factors contribute to cLBP, dysregulation in the hypothalamic-pituitary-adrenal axis and autonomic nervous system functioning have been implicated in its pathogenesis. It is well documented that negative psychological states can modulate biological stress responsivity in chronic pain; however, little is known regarding the influence of positive psychological factors in this relationship. The aim of this study was to examine the association between psychological risk and resilience factors with patterns of physiological stress reactivity and recovery in 60 older adults with cLBP. Participants completed measures of hope, optimism, pain catastrophizing, and perceived stress, and underwent psychophysical pain testing assessing responses to painful pressure, heat, and cold stimuli. Salivary samples were obtained prior to pain induction and at 7 time points spanning 90 minutes after pain testing terminated. To examine reactivity and recovery profiles in hypothalamic-pituitary-adrenal axis and autonomic nervous system function, samples were assayed for cortisol and alpha-amylase, respectively. Results revealed higher levels of hope and optimism were associated with increased cortisol reactivity (p's < .003) and more rapid recovery (p's = .001). Further, pain catastrophizing and perceived stress were associated with cortisol reactivity, with lower levels of these factors predicting larger increases in cortisol from baseline to peak levels (p's < .04). No significant differences in reactivity or recovery patterns emerged for alpha-amylase. Overall, findings highlight the role of psychological risk and resilience factors in modulating physiological stress reactivity. PERSPECTIVE: This article investigated whether psychosocial risk and resilience factors were associated with stress reactivity and recovery in response to laboratory-based pain testing in older adults with chronic low back pain. Results indicate that high resilience factors may be protective by modulating adrenocortical reactivity and recovery profiles.


Subject(s)
Chronic Pain , Hydrocortisone , Resilience, Psychological , alpha-Amylases , Humans , Hydrocortisone/metabolism , Male , Female , Aged , Middle Aged , alpha-Amylases/metabolism , Chronic Pain/physiopathology , Chronic Pain/metabolism , Chronic Pain/psychology , Catastrophization/psychology , Low Back Pain/metabolism , Low Back Pain/physiopathology , Low Back Pain/psychology , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Saliva/metabolism , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Pain Measurement
15.
Dev Psychobiol ; 65(7): e22425, 2023 11.
Article in English | MEDLINE | ID: mdl-37860904

ABSTRACT

Prenatal exposure to maternal depression and serotonin reuptake inhibitor (SRI) antidepressants both affect the development of the hypothalamic-pituitary-adrenal (HPA) system, possibly via the neurotransmitter serotonin (5HT). In a community cohort, we investigated the impact of two factors that shape prenatal 5HT signaling (prenatal SRI [pSRI] exposure and child SLC6A4 genotype) on HPA activity at age 6 years. Generalized estimating equation (GEE) models were used to study associations between cortisol reactivity, pSRI exposure, and child SLC6A4 genotype, controlling for maternal depression, child age, and sex (48 pSRI exposed, 74 nonexposed). Salivary cortisol levels were obtained at five time points during a laboratory stress challenge: arrival at the laboratory, following two sequential developmental assessments, and then 20 and 40 min following the onset of a stress-inducing cognitive/social task. Cortisol decreased from arrival across both developmental assessments, and then increased across both time points following the stress challenge in both groups. pSRI-exposed children had lower cortisol levels across all time points. In a separate GEE model, we observed a lower cortisol stress response among children with LG /S alleles compared with children with La/La alleles, and this was particularly evident among children of mothers reporting greater third trimester depressed mood. Our findings suggest that pSRI exposure and a genetic factor associated with modulating 5HT signaling shaped HPA reactivity to a laboratory stress challenge at school age.


Subject(s)
Depression , Hydrocortisone , Pregnancy Complications , Prenatal Exposure Delayed Effects , Selective Serotonin Reuptake Inhibitors , Child , Female , Humans , Pregnancy , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Cohort Studies , Genetic Variation , Hydrocortisone/analysis , Hydrocortisone/metabolism , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/embryology , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/embryology , Pituitary-Adrenal System/physiopathology , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/genetics , Prenatal Exposure Delayed Effects/metabolism , Prenatal Exposure Delayed Effects/psychology , Selective Serotonin Reuptake Inhibitors/pharmacology , Selective Serotonin Reuptake Inhibitors/therapeutic use , Serotonin Plasma Membrane Transport Proteins/genetics , Serotonin Plasma Membrane Transport Proteins/metabolism , Stress, Psychological/genetics , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Depression/drug therapy , Depression/metabolism , Depression/physiopathology , Serotonin/analysis , Serotonin/metabolism , Saliva/chemistry , Pregnancy Complications/chemically induced , Pregnancy Complications/genetics , Pregnancy Complications/metabolism , Pregnancy Complications/psychology
16.
Article in English | MEDLINE | ID: mdl-34929323

ABSTRACT

INTRODUCTION: Women with bipolar disorder (BD) present a high prevalence of polycystic ovary syndrome (PCOS) and other reproductive disorders even before diagnosis or treatment of the disease. Postulations on the potential molecular mechanisms of comorbid PCOS in women with BD remain limited to influence of medications and need further extension. OBJECTIVES: This review focuses on evidence suggesting that common metabolic and immune disorders may play an important role in the development of BD and PCOS. RESULTS: The literature covered in this review suggests that metabolic and immune disorders, including the dysfunction of the hypothalamic-pituitary-adrenal axis, chronic inflammatory state, gut microbial alterations, adipokine alterations and circadian rhythm disturbance, are observed in patients with BD and PCOS. Such disorders may be responsible for the increased prevalence of PCOS in the BD population and indicate a susceptibility gene overlap between the two diseases. Current evidence supports postulations of common metabolic and immune disorders as endophenotype in BD as well as in PCOS. CONCLUSIONS: Metabolic and immune disorders may be responsible for the comorbid PCOS in the BD population. The identification of hallmark metabolic and immune features common to these two diseases will contribute to the clarification of the effect of BD on the reproductive endocrine function and development of symptomatic treatments targeting the biomarkers of the two diseases.


Subject(s)
Bipolar Disorder , Comorbidity , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/physiopathology , Polycystic Ovary Syndrome , Bipolar Disorder/epidemiology , Bipolar Disorder/physiopathology , Circadian Rhythm/physiology , Female , Humans , Immune System Diseases/complications , Metabolic Diseases/complications , Polycystic Ovary Syndrome/epidemiology , Polycystic Ovary Syndrome/physiopathology
17.
Oxid Med Cell Longev ; 2021: 1703981, 2021.
Article in English | MEDLINE | ID: mdl-34646421

ABSTRACT

Chronic stress is a critical factor in the aetiology of anxiety disorders; however, in the clinic, enduring and preventive measures are not available, and therapeutic drugs are associated with inevitable side effects. Our study established an anxiety rat model using chronic restraint stress (CRS) and assessed these animals using the open-field test, elevated plus-maze test, and light-dark box test. Jie-Yu-He-Huan capsule (JYHH), a Chinese medicine formula, was used as a preventative drug. The HPA axis-mediated release of corticotropin-releasing hormone, adrenocorticotropic hormone, and corticosterone from the hypothalamus was tested. In the hippocampus and prefrontal cortex, concentrations of 5-HT and its metabolite 5-hydroxyindoleacetic acid, as well as monoamine oxidase A, glucocorticoid receptor, and 5-HT1A receptor expression levels, were measured. Furthermore, we examined protein and mRNA expression of cAMP-PKA-CREB-BDNF pathway components. The results showed that JYHH had a significant preventative effect on the anxiety-like behaviour induced by CRS and prevented abnormal changes in the HPA axis and 5-HT system. Furthermore, CRS inhibited the cAMP-PKA-CREB-BDNF pathway, which returned to normal levels following JYHH treatment. This might be the underlying molecular mechanism of the antianxiety effect of JYHH, which could provide a new clinical target for preventative anxiolytic drugs for chronic stress.


Subject(s)
Anti-Anxiety Agents/pharmacology , Anxiety/drug therapy , Brain-Derived Neurotrophic Factor/metabolism , Hypothalamo-Hypophyseal System/metabolism , Pituitary-Adrenal System/metabolism , Animals , Corticosterone/pharmacology , Disease Models, Animal , Hypothalamo-Hypophyseal System/physiopathology , Male , Pituitary-Adrenal System/physiopathology , Rats, Wistar , Restraint, Physical , Stress, Psychological/complications
18.
Neurotoxicol Teratol ; 88: 107038, 2021.
Article in English | MEDLINE | ID: mdl-34678460

ABSTRACT

Adolescent inhalant misuse has a known association with suicidal thoughts and behaviour. This association persists even after inhalant misuse has ceased. Previous studies have hypothesised that this association may derive from socioeconomic disadvantage or vulnerability, and potentially mediated by impulsivity. This association may also be due to the central nervous system depressant effects of inhalants. This review takes a behavioural toxicology perspective, focussed particularly on the serotonergic system and the Hypothalamic-Pituitary-Adrenal (HPA) axis, as potential links between adolescent inhalant misuse and suicidal behaviour. The challenges of bridging the pre-clinical and clinical literature in this area are discussed, along with promising avenues for future research; ultimately aimed at reducing suicide risk in a vulnerable adolescent population group.


Subject(s)
Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/physiopathology , Suicidal Ideation , Administration, Inhalation , Adolescent , Behavior/physiology , Humans , Risk Factors
19.
Sci Rep ; 11(1): 19091, 2021 09 27.
Article in English | MEDLINE | ID: mdl-34580342

ABSTRACT

It has been well documented that chronic stress can induce atherosclerotic changes, however, the underlying mechanisms is yet to be established. In this regard, this study aimed to elucidate the relation between hypothalamic-pituitary adrenal-axis (HPA-axis), toll-like receptors (TLRs), as well as M1/M2 macrophage ratio and pre-atherosclerotic changes in social isolation stress (SIS) in mice. We used small interfering RNA against the glucocorticoid receptor (GR) to evaluate the relation between HPA-axis and TLRs. C57BL/6J mice were subjected to SIS and RT-PCR, ELISA, flow cytometry, and immunohistochemistry were used to assess the relations between pre-atherosclerotic changes and TLRs, macrophage polarization, pro-inflammatory cytokines, and cell adhesion molecules in aortic tissue. We used TAK-242 (0.3 mg/kg, intraperitoneally), a selective antagonist of TLR4, as a possible prophylactic treatment for atherosclerotic changes induced by SIS. We observed that isolated animals had higher serum concentration of corticosterone and higher body weight in comparison to normal animals. In isolated animals, results of in vitro study showed that knocking-down of the GR in bone marrow-derived monocytes significantly decreased the expression of TLR4. In vivo study suggested higher expression of TLR4 on circulating monocytes and higher M1/M2 ratio in aortic samples. Pathological study showed a mild pre-atherosclerotic change in isolated animals. Finally, we observed that treating animals with TAK-242 could significantly inhibit the pre-atherosclerotic changes. SIS can possibly increase the risk of atherosclerosis through inducing abnormal HPA-axis activity and subsequently lead to TLR4 up-regulation, vascular inflammation, high M1/M2 ratio in intima. Thus, TLR4 inhibitors might be a novel treatment to decrease the risk of atherosclerosis induced by chronic stress.


Subject(s)
Atherosclerosis/etiology , Stress, Psychological/complications , Sulfonamides/pharmacology , Toll-Like Receptor 4/antagonists & inhibitors , Animals , Atherosclerosis/physiopathology , Atherosclerosis/prevention & control , Cells, Cultured , Disease Models, Animal , Gene Knockdown Techniques , Humans , Hypothalamo-Hypophyseal System/physiopathology , Macrophage Activation , Male , Mice , Pituitary-Adrenal System/physiopathology , Primary Cell Culture , Receptors, Glucocorticoid/genetics , Receptors, Glucocorticoid/metabolism , Social Isolation/psychology , Stress, Psychological/immunology , Stress, Psychological/metabolism , Stress, Psychological/psychology , Sulfonamides/therapeutic use , Toll-Like Receptor 4/metabolism , Up-Regulation
20.
Front Endocrinol (Lausanne) ; 12: 701263, 2021.
Article in English | MEDLINE | ID: mdl-34489864

ABSTRACT

Introduction: Adrenocorticotropic hormone (ACTH) is produced from proopiomelanocortin, which is predominantly synthetized in the corticotroph and melanotroph cells of the anterior and intermediate lobes of the pituitary gland and the arcuate nucleus of the hypothalamus. Although ACTH clearly has an effect on adrenal homeostasis and maintenance of steroid hormone production, it also has extra-adrenal effects that require further elucidation. Methods: We comprehensively reviewed English language articles, regardless of whether they reported the presence or absence of adrenal and extra-adrenal ACTH effects. Results: In the present review, we provide an overview on the current knowledge on adrenal and extra-adrenal effects of ACTH. In the section on adrenal ACTH effects, we focused on corticosteroid rhythmicity and effects on steroidogenesis, mineralocorticoids and adrenal growth. In the section on extra-adrenal effects, we have analyzed the effects of ACTH on the osteoarticular and reproductive systems, adipocytes, immune system, brain and skin. Finally, we focused on adrenal insufficiency. Conclusions: The role of ACTH in maintaining the function of the hypothalamic-pituitary-adrenal axis is well known. Conversely, if we broaden our vision and analyze its role as a potential treatment strategy in other conditions, it will be evident in the literature that researchers seem to have abandoned this aspect in studies conducted several years ago. We believe it is worth re-evaluating the role of ACTH considering its noncanonical effects on the adrenal gland itself and on extra-adrenal organs and tissues; however, this would not have been possible without the recent advances in the pertinent technologies.


Subject(s)
Adrenal Insufficiency/pathology , Adrenocorticotropic Hormone/metabolism , Pituitary-Adrenal System/physiopathology , Adrenal Insufficiency/metabolism , Animals , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...